Intracellular antibodies and challenges facing their use as therapeutic agents

被引:75
|
作者
Lobato, MN [1 ]
Rabbitts, TH [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
D O I
10.1016/S1471-4914(03)00163-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A key feature of antibodies is their ability to bind antigens with high specificity and affinity. This has led to the concept of intracellular antibodies (intrabodies), designed to mimic antibody-antigen binding, but inside cells. Antibody fragments comprising the antigen-binding variable domains are convenient formats for intrabodies, potentially allowing for intracellular functionality. Intrabodies are promising tools, capable of interfering with a wide range of molecular targets in various intracellular compartments. However, many significant challenges remain to be overcome before intrabodies can be useful therapeutic agents. Although major progress has been made in the design and selection of intrabodies, new developments and advances are needed to allow their efficient delivery and expression for treatment of human diseases.
引用
收藏
页码:390 / 396
页数:7
相关论文
共 50 条
  • [41] Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications
    Cao, T
    Heng, BC
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (03): : 227 - 229
  • [42] Patentability of antibodies for therapeutic use in Europe
    Claudio Germinario
    Sara Bertoli
    Patrizia Rampinelli
    Maurizio Cini
    Nature Biotechnology, 2018, 36 : 402 - 405
  • [43] Therapeutic drug monitoring of intracellular anti-infective agents
    D'Avolio, Antonio
    Pensi, Debora
    Baietto, Lorena
    Di Perri, Giovanni
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 101 : 183 - 193
  • [44] Functionalized graphene sheets for intracellular controlled release of therapeutic agents
    Tu, Zhaoxu
    Wycisk, Virginia
    Cheng, Chong
    Chen, Wei
    Adeli, Mohsen
    Haag, Rainer
    NANOSCALE, 2017, 9 (47) : 18931 - 18939
  • [45] THERAPEUTIC USE OF COMBINATIONS OF ANTIBIOTIC AGENTS
    READER, G
    JAWETZ, E
    MCDERMOTT
    GOLD, H
    NEW YORK STATE JOURNAL OF MEDICINE, 1953, 53 (10) : 1228 - 1233
  • [46] THERAPEUTIC USE OF NEWER ANTIVIRAL AGENTS
    SACKS, SL
    INTERNATIONAL JOURNAL OF CELL CLONING, 1986, 4 : 155 - 173
  • [47] Therapeutic use of alkalinising agents in the pharmacy
    van Schoor, Jacqueline
    SA PHARMACEUTICAL JOURNAL, 2010, 77 (04) : 25 - 27
  • [48] USE OF THERAPEUTIC AGENTS IN MASTITIS CONTROL
    VANOS, JL
    NETHERLANDS MILK AND DAIRY JOURNAL, 1982, 36 (03): : 272 - 273
  • [49] The challenges with developing therapeutic monoclonal antibodies for pandemic application
    Laustsen, Andreas H.
    Bohn, Markus-Frederik
    Ljungars, Anne
    EXPERT OPINION ON DRUG DISCOVERY, 2022, 17 (01) : 5 - 8
  • [50] Advances and challenges in therapeutic monoclonal antibodies drug development
    dos Santos, Mariana Lopes
    Quintilio, Wagner
    Manieri, Tania Maria
    Tsuruta, Lilian Rumi
    Moro, Ana Maria
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54